The most commonly reported side effects of GLP-1 therapy include nausea, vomiting, constipation, diarrhea, bloating, burping, and dizziness
However individuals with certain medical conditions, pregnancy, or known allergies should always consult a qualified medical professional before starting treatment
However, preventing weight regain typically requires continued lifestyle changes or a full-dose tirzepatide program
Regular review of weight loss progress, typically every three months, allows assessment of treatment response and consideration of whether continuation is appropriate according to NICE TA875, which recommends discontinuation if less than 5% weight loss is achieved after six months at the maintenance dose
Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE, Heideman RL: Hidden central hypothyroidism in survivors of childhood cancer
(PubMed) Ashor AW, Siervo M, Lara J, Oggioni C, Afshar S, Mathers JC